| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0035 | 1 |